The finding of ZNF224 as one of the factors enhancing NF-kB signaling may contribute to clarify the molecular mechanisms of NF-kB deregulation in CLL and to develop new strategies for targeting this pathway. Here, ZNF224 is linked to B-cell chronic lymphocytic leukemia.